Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of nearly $9.5 billion ... Read More >>

Recent News

11/15/17

LabCorp Announces New Expanded Use for PD-L1 Test with Bristol-Myers Squibb’s OPDIVO®

11/13/17

LabCorp Receives 2017 Partnership Award from Be The Match®

11/13/17

LabCorp Earns 100 Percent on Human Rights Campaign Foundation’s 16th Annual Scorecard on LGBTQ Workplace Equality

Upcoming Events

There are currently no events scheduled.

LH (Common)
ExchangeNYSE
Price$152.48
Change Stock is Up 1.76
Data as of 11/21/17 12:09 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet